Success with Zepbound should be measured beyond weight loss alone, including improvements in metabolic health, energy levels, and overall quality of life
10.1007/s004019900159 151 SatputeR.LomashV.KaushalM.BhattacharyaR
Sorry for this being a bit all over the place but obesity had destroyed me, and I finally have hope again
injectable), and starting dosesupporting a more personalized, evidence-informed decision-making process
Our study demonstrates the potential of AOMs, particularly tirzepatide and semaglutide, in mitigating OSA risk among patients with obesity
Studies have shown that higher doses of tirzepatide tend to result in a higher rate of gastrointestinal side effects, including diarrhea